Impact of anemia treatment for left ventricular hypertrophy using long-acting erythropoietin-stimulating agents from the pre-dialysis to maintenance dialysis period in patients with chronic kidney disease, retrospective longitudinal cohort study

BACKGROUND: Anemia in patients with chronic kidney disease (p-CKDs) may initiate or exacerbate left ventricular hypertrophy (LVH). This study aimed to determine whether treatment using long-acting erythropoietin-stimulating agents (L-ESAs) is independently associated with LVH during the pre-dialysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Io, Hiroaki, Muto, Masahiro, Sasaki, Yu, Ishizaka, Masanori, Kano, Toshiki, Fukuzaki, Haruna, Maeda, Takuya, Shimizu, Yuki, Nakata, Junichiro, Suzuki, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039592/
https://www.ncbi.nlm.nih.gov/pubmed/36966289
http://dx.doi.org/10.1186/s12882-023-03133-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039592/
https://www.ncbi.nlm.nih.gov/pubmed/36966289
http://dx.doi.org/10.1186/s12882-023-03133-1

Ejemplares similares